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Abstract
Background: On March 16, 2020, the first death from CO-
VID-19 was recorded in Portugal. Since then, there has been 
a reorganization of health services, changing the normal ap-
proach for the different cases of public health. Excess deaths 
recorded without a COVID-19 diagnosis are called excess 
mortality without COVID-19 (EM non-COVID-19). This study 
aims to estimate the EM non-COVID in the 7-month period 
after the first registered Covid-19 death. Methods: The fol-
lowing 2 methods were used to estimate the excess mortal-
ity in this period: the daily historical average of reported 
deaths and an adapted auto regressive integrated moving 
average (ARIMA) model, considering the previous 5 years of 
records until October 16. For this model, after March 16, data 
was replaced with the daily historical average deaths from 
the previous 5 years, simulating the closest scenario possible 
as there was no pandemic. Only deaths from natural causes 
were selected for these estimations. For EM non-COVID-19 
estimation, we subtracted the COVID-19 deaths from the 
overall excess mortality. Results: Between March 16, 2020, 
and October 16, 2020, there was an excess of 6,330 deaths 
from natural causes, i.e., nearly 12% more than expected. 
Both methods estimated an EM non-COVID-19 of around 
66–67% in this period, with a greater relevance in mid-July 
and mid-September. Conclusions: Excess mortality was 
present almost every day during the study period. EM non-
COVID-19 seemed to vary over time, showing some inade-
quacy of healthcare services in management of other pa-
tients free of COVID-19 in Portugal during periods with a 
greater patient volume. It is necessary to take care and mon-
itor COVID-19 cases but also non-COVID-19 cases.
© 2021 The Author(s) Published by S. Karger AG, Basel  
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Resumo
Introdução: Em 16 de março de 2020 foi registado em 
Portugal o primeiro óbito por COVID-19. Desde então, 
houve uma reorganização dos serviços de saúde, resul-
tando numa alteração do funcionamento dos serviços de 
saúde pública. O excesso de óbitos registados sem CO-
VID-19 é denominado de Excesso de Mortalidade não-CO-
VID-19 (EM não-COVID-19). O objetivo deste estudo é es-
timar a EM não-COVID-19 nos primeiros 7 meses após o 
primeiro óbito por COVID-19 em Portugal. Métodos: Dois 
métodos foram utilizados para estimar a Mortalidade Ex-
cessiva neste período: A média histórica diária de óbitos 
notificados e um modelo Autorregressivo Integrado de 
Média Móvel (ARIMA) adaptado, considerando os 5 anos 
anteriores de registos até 16 de outubro. Para este mod-
elo, a partir de 16 de março, os dados foram substituídos 
pela média histórica diária de mortes dos 5 anos anteri-
ores, simulando um cenário mais aproximado possível 
caso não existisse pandemia. Apenas mortes devido a 
causas naturais foram selecionadas. Para a estimativa do 
EM não-COVID-19, subtraímos as mortes por COVID-19 à 
mortalidade geral em excesso. Resultados: Entre 16 de 
março de 2020 e 16 de outubro de 2020, houve um exce-
dente de 6 330 mortes por causas naturais, cerca de 12% 
a mais do que o esperado. Ambos os métodos estimaram 
um EM não-COVID-19 em torno de 66–67% neste período, 
com maior relevância em meados de julho e meados de 
setembro. Conclusões: O excesso de mortalidade esteve 
presente quase todos os dias no período de estudo. O EM-
não COVID-19 pareceu ter alguma variação ao longo do 
tempo, evidenciando que momentos com maior volume 
se possam dever a alguma inadequação dos serviços de 
saúde na gestão de outros doentes sem COVID-19 em 
Portugal. É necessário continuar a cuidar e a monitorar os 
casos COVID-19, mas também os outros casos não CO-
VID-19. © 2021 The Author(s) Published by S. Karger AG, Basel  
on behalf of NOVA National School of Public Health
Background
On March 2, 2020, the first positive COVID-19 case in 
Portugal was recorded, i.e., 13 days before the first death 
was observed [1]. Since then, several political strategies 
and reorganizations in all sectors have been required, 
from restrictions on the economic sector and people’s 
mobility, to health services prioritizing the treatment of 
this new disease [2].
Different measures have been applied worldwide to 
fight the virus, but the record of positive cases and deaths 
registered for this disease is transversal to all countries. In 
Europe, the countries with the highest overall case fatal-
ity rates until October 16 were Italy (9.53%), United King-
dom (6.44%), and Sweden (5.77%), but these rates vary 
when analyzed by age group [3, 4]. This cross-country 
estimation may have a nonnegligible degree of error due 
to different criteria for testing adopted by each country 
over time [5, 6]. Portugal recorded 95,902 cases of CO-
VID-19 and 2,149 deaths from COVID-19 on October 16, 
stating a case fatality rate of 2.24% at that point [1].
The excess mortality registered above the expected val-
ues without including deaths caused by COVID-19 (EM 
non-COVID-19) may be attributed to collateral effects of 
this pandemic [7] but also to other reasons. The term 
“collateral mortality” was used to define the number of 
deaths caused by delayed or postponed treatment due to 
the focus of healthcare services on COVID-19 cases, and 
it is likely to represent a large portion of the EM-non-
COVID-19 [8]. The main goal of this study is to estimate 
the EM non-COVID-19 in the 7 months after the first 
reported COVID-19 death in Portugal.
Materials and Methods
Mortality data was extracted from the Portuguese Death Cer-
tificate Information System (SICO-eVM) [9]. We only extracted 
the number of deaths from natural causes, as we consider that 
deaths caused by external causes (such as traffic accidents or vio-
lence) should not be included in the analysis of EM non-CO-
VID-19 since COVID-19 deaths are registered as deaths from nat-
ural causes only. Data on the number of reported COVID-19 
deaths in Portugal was extracted from the Directorate-General of 
Health (DGS) daily Situation Reports, where all persons who died 
with COVID-19 were counted, unless another obvious and un-
equivocal cause of death (like a car accident) was identified [10].
We used the following 2 methods to estimate the expected val-
ues of daily mortality: (1) in the historical average method, we cal-
culated the historical average of the number of daily all-cause mor-
tality cases for the last 5 years, between March 16 and October 16, 
and those values are considered the expected value for 2020 if there 
had been no pandemic; (2) in the ARIMA method, we modeled a 
time series including the observed mortality from January 1, 2010, 
to March 15, 2020, and the historical average after that day from 
March 16, 2020, to October 16, 2020. This cut-off point (March 16) 
was the date of the first reported COVID-19 death and the close 
inversion in mortality trend. We compared the observed and mod-
eled expected mortality for the pandemic period and the respective 
95% CI. The models were adjusted with a coefficient of determina-
tion of R2 = 0.823 (Ljung-Box test, not statistically significant; au-
tocorrelation function and partial autocorrelation function, not 
statistically significant in the residues; and estimates of the auto 
parameters – statistically significant regression and moving aver-
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ages; p < 0.01) [11]. Tests were performed in IBM® SPSS software 
version 24.
These 2 methods were applied for validation of the results, as 
performed before in another study [7]. Excess mortality is all the 
deaths registered above those expected values.
EM non-COVID-19 was calculated by considering the number 
of non-COVID-19 deaths above the expected values for each 
method, considering the period of the study. Calculation of the 
number of excess non-COVID-19 deaths per day was performed 
by subtracting the total deaths registered free of COVID-19 from 
the predicted deaths estimated by the ARIMA model, for each day. 
Then, we calculated the daily proportion of EM non-COVID-19 
by dividing the amount of EM non-COVID-19 deaths by all deaths 
registered beyond the expected values. Days without non-CO-
VID-19 deaths beyond the expected values were valued as 0%.
Results
Historical Average Method
For the period in consideration, there were 2,149 
deaths with COVID-19. Figure 1 shows the mortality 
over time.
Table 1 shows the estimated excess mortality for natu-
ral causes between March 16 and October 16.
These result presents an EM non-COVID-19 estima-
tion of 67.0% within the value above the average deaths of 
the last 5 years (excess mortality non-COVID-19 deaths/
all excess mortality) or 7.3% of the total observed deaths 
(excess mortality non-COVID-19 deaths/all deaths).
ARIMA Modeling
The ARIMA model found similar results, which can be 
seen in Figure 2.
Through the ARIMA method, 53,573 deaths caused by 
natural causes were predicted in the period between 
March 16 and October 16. There were 6,330 more deaths 
than predicted in the forecast if there had been no pan-
demic. If we remove the deaths registered as COVID-19 
(2,149 deaths), we register an EM non-COVID-19 of 
about 4,181 deaths. This represents 66.1% of the regis-
tered excess mortality or 7.0% of the total deaths regis-
tered by natural causes.
Figure 3 shows an illustration that can help to under-
stand the results.
Also, in Figure 4, we can see the EM non-COVID-19 
per day as frequencies and percentages.
Between April and mid-June, COVID-19 deaths con-
tributed, to some degree, to the excess mortality seen in 
Portugal. However, since early July, excess mortality was 
present almost every day, with main deaths bellowing to 
non-direct COVID-19 diagnoses. Although the daily 
contribution of non-COVID-19 deaths to the daily excess 
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% (deaths in 
2020/average 
in the last 5 
years)
All deaths 59,906 53,386 6,520 +12.2
Non-COVID-19 deaths 57,757 4,371 +8.9
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VID-19 deaths has largely oscillated and it is therefore not 
possible to identify a clear trend. The proportions of non-
COVID-19 deaths seemed to increase from mid-April to 
mid-July but from mid-July to mid-September they 
seemed to remain stable (and high), decreasing until mid-
October. Excess mortality existed and was mainly attrib-



























































































































































■ Predicted value ■ COVID-19 deaths ■ Excess mortality non-COVID-19
Fig. 2. Evolution of mortality due to natural 
causes only, analyzed using the ARIMA 
model.
Fig. 3. Schematic representation of the 
mortality in Portugal between March 16 
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Discussion/Conclusion
The findings of our analysis suggest an EM non-CO-
VID-19 between 66.1 and 67.0% for the COVID-19 pan-
demic in Portugal for the period between March 16 and 
October 16, 2020. This percentage is related to the excess 
mortality calculated for natural causes only.
The results are consistent, using 2 different methods 
for estimation, as performed in an earlier study at the be-
ginning of the pandemic [7]. In that study, we found that 
nearly 1 month after the first registered COVID-19 death 
in Portugal the EM non-COVID-19 was around 51%. Re-
gardless of the lockdown measures and restrictions ap-
plied over time, this percentage increased after 6 months, 
which means that, in general, we still observed a sum of 
deaths above the expected values and more of them were 
registered as causes other than COVID-19 [2]. These are 
important findings, as we expected the arrival of the win-
ter to drastically increase coronavirus [12]. In fact, the 
pressure on the health system was greater this October 
2020 compared to the summer time, potentially due to a 
greater period of access to hospitals and health services, 
even without the typical activity of flu expected for this 
time of the year [1, 13, 14]. The reduction in the incidence 
of others respiratory infections could have contributed to 
mitigation of the verified excess mortality.
On October 16, Portugal had an incidence of CO-
VID-19 mortality of 20.91/100.000, being classified as a 
country with a moderate mortality due to COVID-19 at 
the time [1, 15]. One explanation for this excess can be the 
impact of heat waves. According to the World Meteoro-
logical Organization (WCDMP No.47, WMO-TD No. 
1071), a heat wave is defined as an interval of at least 6 
consecutive days during which the maximum daily tem-
perature is 5  ° C higher than the average daily value in the 
reference period [16]. Thus, there may have been a heat 
wave in the periods from May 24 to 29 and from July 15 

































































































































Port J Public Health6
DOI: 10.1159/000515656
for EM non-COVID-19 [17]. Therefore, the hypothesis 
that people’s health deteriorated and they possibly died 
due to spiking temperatures, while not seeking medical 
attention due to fear of COVID-19 and medical care not 
being focused on these episodes, should not be ruled out. 
However, the increase in EM non-COVID-19 in mid-
September cannot be attributed to temperature variations 
and thus other causes may be underlying this phenome-
non.
Recently, a study of Tanne [18] showed that 33% of 
deaths between March and July 2020 throughout the USA 
were EM non-COVID-19 deaths [18]. Woolf et al. [19] 
found that these percentages of EM non-COVID-19 
deaths could vary from none to nearly 83%, depending on 
the state. In Europe, estimations require more updates. In 
a recent article by Kontis et al. [20], it was estimated that 
in late May 2020 England and Wales, Italy, and Spain had 
57,300, 48,700, and 45,800 excess deaths, respectively, 
while Portugal recorded 2,900. Respectively, the rates of 
EM non-COVID-19 significantly differed between those 
countries (i.e., 28.8, 32.5, 61.8, and 51.9%). These values 
are relevant tools for policy makers, as they help to under-
stand whether the excess deaths counted are primarily 
due to the management of COVID-19 cases or the man-
agement of other disease cases.
Kontis et al. [20] and Woolf et al. [19] hypothesized 
that some of the excess deaths could have been due to 
undiagnosed COVID-19; however, we considered this 
a very remote supposition in Portugal as, since mid-
March, the criteria for postmortem testing for CO-
VID-19 were broad and updated through time [21]. In 
the UK, it was found that about 7.8% of deaths with 
COVID-19 on the death certificate but not stated as the 
underlying cause were not considered a “COVID-19 
death” [22]. However, we think that the death certifi-
cate system in Portugal registered most people who 
died with COVID-19 (even if it was not the underlying 
cause) in the category of COVID-19 deaths, as since 
April Portugal adopted the practice of counting deaths 
with COVID-19 and not only by COVID-19 [23]. So, 
we believe that the number of deaths with COVID-19 
misclassified should not be significant. Other possible 
contributions to those high numbers of EM non-CO-
VID-19 can be explained by the population being afraid 
to seek hospital emergency services due to the risk of 
becoming infected, or the healthcare services’ inability 
to provide the regular quality of service to non-CO-
VID-19 patients after the organizational restructurings 
[2, 17], i.e., the so called earlier collateral mortality. The 
availability of daily data used by the health services and 
specific causes of death can contribute to other parallel 
analyses that could better explain these results.
In the study period, the maximum bed occupation due 
to patients with COVID-19 in intensive care units was 
271, on April 7, out of 511 beds available before the pan-
demic [10]. That represents more than half of the inten-
sive care unit beds occupied by COVID-19 cases. The 
pandemic’s age distribution is also changing over time, 
with mostly young people apparently currently being af-
fecting [10]. Although this subpopulation has a greater 
capacity to survive the disease, an increasing number of 
overall cases would nonetheless overload the healthcare 
systems and more cases of deaths among younger people 
have been described. The underuse of health services, 
stringency measures, and public behavior regarding mea-
sures may play a big role in the mortality soon.
The methodology used in this study has some limita-
tions. First, the use of the average value of the last 5 years 
without considering any standard of error does not reach 
the variability of reported deaths through the years for the 
same day. Also, the expected values of excess deaths may 
be overestimated, considering the long-term trend of 
mortality due to demographic, health, and social changes 
(between 2015 and 2019, the sum of the variation in the 
mortality growth rate from one year to the next, yielded 
an overall rate of 1.3%, but 2019 had a value of –1.1% re-
lated to 2018 so we did not assume that this was relevant 
for these estimations, considering the short period) [24].
We found our study to be one of the few studies esti-
mating excess mortality from natural causes (instead of 
overall causes) during the COVID-19 pandemic. Further 
research is needed to better understand the drivers of ex-
cess mortality during the COVID-19 pandemic in differ-
ent periods of time, considering healthcare supply and 
demand (including changes in consultations, surgery, 
and emergency services used by patients) and social, be-
havioral, and economic changes that may impact mortal-
ity through different mechanisms.
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